John Wiley & Sons, Inc. (WLYB) stock
WLYBNYSEBooks: Publishing or Publishing & PrintingFiscal year ends April 30Also trades as WLY
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 16/3013% below fair value
$51.60−2.63 (-4.86%)
Close on Oct 30, 2026Market cap $2.62BP/E 13.9Yield –
John Wiley & Sons EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
John Wiley & Sons's EPS for the twelve months ending Jul 31, 2026 was $3.73, up 110.7% year over year. For fiscal 2026 it was $4.16, up 171.9% from the year before. Over ten years it grew 5.3% a year on average. The highest annual figure on record is $4.16 in fiscal 2026.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | $4.16 | +171.9% |
| FY2025 | Apr 30, 2025 | $1.53 | – |
| FY2024 | Apr 30, 2024 | -$3.65 | -1277.4% |
| FY2023 | Apr 30, 2023 | $0.31 | -88.2% |
| FY2022 | Apr 30, 2022 | $2.62 | -0.4% |
| FY2021 | Apr 30, 2021 | $2.63 | – |
| FY2020 | Apr 30, 2020 | -$1.32 | -145.4% |
| FY2019 | Apr 30, 2019 | $2.91 | -12.3% |
| FY2018 | Apr 30, 2018 | $3.32 | +70.3% |
| FY2017 | Apr 30, 2017 | $1.95 | -21.4% |
| FY2016 | Apr 30, 2016 | $2.48 | -16.5% |
| FY2015 | Apr 30, 2015 | $2.97 | +10.0% |
| FY2014 | Apr 30, 2014 | $2.70 | +13.0% |
| FY2013 | Apr 30, 2013 | $2.39 | -31.1% |
| FY2012 | Apr 30, 2012 | $3.47 | +23.9% |
| FY2011 | Apr 30, 2011 | $2.80 | +16.2% |
| FY2010 | Apr 30, 2010 | $2.41 | +12.1% |
| FY2009 | Apr 30, 2009 | $2.15 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027 | Jul 31, 2026 | -$0.23 | -204.5% |
| Q4 FY2026 | Apr 30, 2026 | $2.56 | +106.5% |
| Q3 FY2026 | Jan 31, 2026 | $0.56 | – |
| Q2 FY2026 | Oct 31, 2025 | $0.84 | +13.5% |
| Q1 FY2026 | Jul 31, 2025 | $0.22 | – |
| Q4 FY2025 | Apr 30, 2025 | $1.24 | +169.6% |
| Q3 FY2025 | Jan 31, 2025 | -$0.43 | – |
| Q2 FY2025 | Oct 31, 2024 | $0.74 | – |
| Q1 FY2025 | Jul 31, 2024 | -$0.03 | – |
| Q4 FY2024 | Apr 30, 2024 | $0.46 | -60.7% |
| Q3 FY2024 | Jan 31, 2024 | -$2.08 | – |
| Q2 FY2024 | Oct 31, 2023 | -$0.35 | -151.5% |
| Q1 FY2024 | Jul 31, 2023 | -$1.67 | – |
| Q4 FY2023 | Apr 30, 2023 | $1.17 | +53.9% |
| Q3 FY2023 | Jan 31, 2023 | -$1.29 | -304.8% |
| Q2 FY2023 | Oct 31, 2022 | $0.68 | -31.3% |
| Q1 FY2023 | Jul 31, 2022 | -$0.32 | -233.3% |
| Q4 FY2022 | Apr 30, 2022 | $0.76 | +4.1% |
| Q3 FY2022 | Jan 31, 2022 | $0.63 | +61.5% |
| Q2 FY2022 | Oct 31, 2021 | $0.99 | -18.9% |
| Q1 FY2022 | Jul 31, 2021 | $0.24 | -17.2% |
| Q4 FY2021 | Apr 30, 2021 | $0.73 | – |
| Q3 FY2021 | Jan 31, 2021 | $0.39 | -38.1% |
| Q2 FY2021 | Oct 31, 2020 | $1.22 | +54.4% |
| Q1 FY2021 | Jul 31, 2020 | $0.29 | +383.3% |
| Q4 FY2020 | Apr 30, 2020 | -$2.83 | -357.3% |
| Q3 FY2020 | Jan 31, 2020 | $0.63 | +3.3% |
| Q2 FY2020 | Oct 31, 2019 | $0.79 | +3.9% |
| Q1 FY2020 | Jul 31, 2019 | $0.06 | -86.7% |
| Q4 FY2019 | Apr 30, 2019 | $1.10 | +18.3% |
| Q3 FY2019 | Jan 31, 2019 | $0.61 | -48.7% |
| Q2 FY2019 | Oct 31, 2018 | $0.76 | -26.9% |
| Q1 FY2019 | Jul 31, 2018 | $0.45 | +181.3% |
| Q4 FY2018 | Apr 30, 2018 | $0.93 | +14.8% |
| Q3 FY2018 | Jan 31, 2018 | $1.19 | +45.1% |
| Q2 FY2018 | Oct 31, 2017 | $1.04 | – |
| Q1 FY2018 | Jul 31, 2017 | $0.16 | – |
| Q4 FY2017 | Apr 30, 2017 | $0.81 | – |
| Q3 FY2017 | Jan 31, 2017 | $0.82 | – |
| Q2 FY2017 | Oct 31, 2016 | -$0.20 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics